Showing 1 - 20 results of 32,920 for search '(( 50 ((a decrease) OR (_ decrease)) ) OR ((( 6 men decrease ) OR ( 5 step decrease ))))*', query time: 0.99s Refine Results
  1. 1
  2. 2
  3. 3
  4. 4

    Supplementary Material for: Cardiac Troponin Is Elevated in Patients with Thyrotoxicosis and Decreases as Thyroid Function Improves and Brain Natriuretic Peptide Levels Decrease by Watanabe N. (4118812)

    Published 2020
    “…At baseline, median hsTnI was 1.9 pg/mL and ranged from 0 to 69.6 pg/mL. Five patients (3.5%) had a high hsTnI value that exceeded 26.2 pg/mL, which is used as the cutoff for diagnosis of myocardial infarction, and 22 patients (15.4%) had an intermediate value between 5.0 and 26.2 pg/mL. …”
  5. 5

    Juvenile demyelination leads to a substantial decrease in potassium currents in PV interneurons of the PFC. by Sara Hijazi (21656615)

    Published 2025
    “…<p><b>A.</b> Representative traces of potassium currents evoked with 10 mV potential steps from −70mV to +60 mV in PFC PV interneurons from control (black) and cuprizone (red) mice. …”
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13

    Decreased oscillatory flow decreases <i>klf2a</i> expression. by Julien Vermot (257990)

    Published 2009
    “…<p>(A) RFF is decreased by alterations in heart rate. …”
  14. 14
  15. 15

    Decreased macrophage recruitment correlates with decreased angiogenesis. by Johanna R. Reed (306158)

    Published 2013
    “…<p>A) Quantification of BrdU incorporation demonstrates that decreased macrophage infiltration does not significantly correlate with a change in epithelial cell proliferation (N.S. = not significant). …”
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20

    Pre-treatment LLM, month of start and end of sustained (≥ 4 months) decrease in LLM by ≥ 50% from pre-treatment LLM, to < 8100 mf/ml or < 30000 mf/ml by treatment arm for participants with a sustained decrease by ≥ 50%. by Joseph Kamgno (81039)

    Published 2016
    “…<p>Pre-treatment LLM, month of start and end of sustained (≥ 4 months) decrease in LLM by ≥ 50% from pre-treatment LLM, to < 8100 mf/ml or < 30000 mf/ml by treatment arm for participants with a sustained decrease by ≥ 50%.…”